Specific therapy and medicament using integrin ligands for treating cancer
Details for Australian Patent Application No. 2008277904 (hide)
International Classifications
Event Publications
11 March 2010 PCT application entered the National Phase
PCT publication WO2009/010287 Priority application(s): WO2009/010287
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008277907-Engineered anti-alpha Vintegrin hybrid antibodies
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser